The advertisement promotes CABOMETYX, a medication for previously treated pancreatic neuroendocrine tumors, highlighting its dosage options and providing a call to action to learn more.
Creative Information
| CID: | dbeff5c8-11e5-46aa-8ccd-7e1ff1f50882 |
| CRID: | 82_6157-850394 |
| Domain: | exelixis.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $0.47 |
| Timestamp: | 10/31/2025, 6:11:45 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 7:21:05 PM | 6.33s | |
| adomain_analysis | success | 10/31/2025, 9:18:01 PM | 2.65s | |
| adomain_capture | success | 10/31/2025, 9:17:59 PM | 0.12s | |
| ad_render | success | 10/31/2025, 7:20:59 PM | 25.70s | |
| brand_mapping | success | 10/31/2025, 6:11:46 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: Exelixis
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1586.32 KB | ||||||||||||||||||||||
| Render Time: | 9.94 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1597.13 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
